Regulation of Glucose-6-phosphatase Gene Expression by Protein Kinase Bα and the Forkhead Transcription Factor FKHR
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Glucose-6-phosphatase plays an important role in the regulation of hepatic glucose production, and insulin suppresses glucose-6-phosphatase gene expression. Recent studies indicate that protein kinase B and Forkhead proteins contribute to insulin-regulated gene expression in the liver. Here, we examined the role of protein kinase B and Forkhead proteins in mediating effects of insulin on glucose-6-phosphatase promoter activity. Transient transfection studies with reporter gene constructs demonstrate that insulin suppresses both basal and dexamethasone/cAMP-induced activity of the glucose-6-phosphatase promoter in H4IIE hepatoma cells. Both effects are partially mimicked by coexpression of protein kinase Balpha. Coexpression of the Forkhead transcription factor FKHR stimulates the glucose-6-phosphatase promoter activity via interaction with an insulin response unit (IRU), and this activation is suppressed by protein kinase B. Coexpression of a mutated form of FKHR that cannot be phosphorylated by protein kinase B abolishes the regulation of the glucose-6-phosphatase promoter by protein kinase B and disrupts the ability of insulin to regulate the glucose-6-phosphatase promoter via the IRU. Mutation of the insulin response unit of the glucose-6-phosphatase promoter also prevents the regulation of promoter activity by FKHR and protein kinase B but only partially impairs the ability of insulin to suppress both basal and dexamethasone/cAMP-stimulated promoter function. Taken together, these results indicate that signaling by protein kinase B to Forkhead proteins can account for the ability of insulin to regulate glucose-6-phosphatase promoter activity via the IRU and that other mechanisms that are independent of the IRU, protein kinase B, and Forkhead proteins also are important in mediating effects of in insulin on glucose-6-phosphatase gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second liver-specific effect of insulin is to repress the expression of the phosphoenolpyruvate carboxykinase and G-6-Pase genes; the first by disrupting the association of cAMP response element-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter,23 whereas G-6-P suppression requires PKBα/Akt and forkhead transcription factor (FOXO1),24, 25 whose”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [25]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Mechanism of activation of protein kinase B by insulin and IGF-1.
Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,004
Self-citationOgg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., & Ruvkun, G. (1997) · Nature · doi:10.1038/40194 · Cited by 1,932
The PI3K‒PDK1 connection: more than just a road to PKB
Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460561 · Cited by 1,644
Self-citationLin, K., Dorman, J. B., Rodan, A., & Kenyon, C. (1997) · Science · doi:10.1126/science.278.5341.1319 · Cited by 1,495
Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5
Clark, K. L., Halay, E. D., Lai, E., & Burley, S. K. (1993) · Nature · doi:10.1038/364412a0 · Cited by 1,274
Biggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., Ruiter, N. D. D., De Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 882
Negative Regulation of the Forkhead Transcription Factor FKHR by Akt
Tang, E. D., Nuñez, G., Barr, F. G., & Guan, K.-L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16741 · Cited by 761
Research works printed but not linked: 5
- Lange, 1994, Biochem. Cell Biol., 201, 302
- Schmoll, 1999, Biochem. J., 338, 457, 10.1042/bj3380457 · doi:10.1042/bj3380457 · Paper page
- Vanhaesebroeck, 2000, Biochem. J., 346, 561, 10.1042/bj3460561 · doi:10.1042/bj3460561 · Paper page
- Durham, 1999, Endocrinology, 140, 3140, 10.1210/endo.140.7.6856 · doi:10.1210/endo.140.7.6856 · Paper page
- Wang, 1999, Mol. Endocrinol., 13, 604
Cited by
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
“In previous studies, insulin suppressed PEPCK and G6PC expression, which are known to increase hepatic gluconeogenesis by activating the PI3K/AKT pathway [84-86].”
BackgroundInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
“FOXO1 has been shown to bind directly to the promoters of gluconeogenic genes and activate the process of glucose productio”
BackgroundFOXO transcription factors at the interface between longevity and tumor suppression
Greer, E. L., & Brunet, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209086 · Cited by 1,310
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,133
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Redox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747
Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism
Nogueiras, R., Habegger, K. M., Chaudhary, N., Finan, B., Banks, A. S., Dietrich, M. O., Horvath, T. L., Sinclair, D. A., Pfluger, P. T., & Tschöp, M. H. (2012) · Physiological Reviews · doi:10.1152/physrev.00022.2011 · Cited by 711
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Guo, S. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 623
Self-citationPuig, O., Marr, M. T., Ruhf, M. L., & Tjian, R. (2003) · Genes & Development · doi:10.1101/gad.1098703 · Cited by 619
Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., Nakajima, T., & Fukamizu, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400593101 · Cited by 602
FoxO proteins in insulin action and metabolism
Barthel, A., Schmoll, D., & Unterman, T. G. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.03.010 · Cited by 604
Self-citationFoxO transcription factors in the maintenance of cellular homeostasis during aging
Salih, D. A., & Brunet, A. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.02.005 · Cited by 604
Insulin regulation of gluconeogenesis
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13435 · Cited by 587
Carter, M. E., & Brunet, A. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.008 · Cited by 581
Rhee, J., Inoue, Y., Yoon, J. C., Puigserver, P., Fan, M., Gonzalez, F. J., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730870100 · Cited by 567
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., & Fukamizu, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934283100 · Cited by 535
FoxO1 Regulates Multiple Metabolic Pathways in the Liver
Zhang, W., Patil, S., Chauhan, B., Guo, S., Powell, D. R., Le, J., Klotsas, A., Matika, R., Xiao, X., Franks, R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600272200 · Cited by 516
Self-citationNovel concepts in insulin regulation of hepatic gluconeogenesis
Barthel, A., & Schmoll, D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00253.2003 · Cited by 515
Self-citationThe glucose-6-phosphatase system
SCHAFTINGEN, E. V., & Gerin, I. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620513 · Cited by 495
FOUFELLE, F., & FERRÉ, P. (2002) · Biochemical Journal · doi:10.1042/bj20020430 · Cited by 479
Tran, H., Brunet, A., Griffith, E. C., & Greenberg, M. E. (2003) · Science's STKE · doi:10.1126/stke.2003.172.re5 · Cited by 434
Finch, C. E., & Ruvkun, G. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.435 · Cited by 446
A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR
Ramaswamy, S., Nakamura, N., Sansal, I., Bergeron, L., & Sellers, W. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00086-7 · Cited by 428
Kim, Y. D., Park, K.-G., Lee, Y.-S., Park, Y.-Y., Kim, D.-K., Nedumaran, B., Jang, W. G., Cho, W.-J., Ha, J., Lee, I.-K., et al. (2008) · Diabetes · doi:10.2337/db07-0381 · Cited by 422
Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., & Fukamizu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314322200 · Cited by 364
Transcriptional feedback control of insulin receptor by dFOXO/FOXO1
Puig, O., & Tjian, R. (2005) · Genes & Development · doi:10.1101/gad.1340505 · Cited by 360
Yan, H., Yang, W., Zhou, F., Li, X., Pan, Q., Shen, Z., Han, G., Newell-Fugate, A., Tian, Y., Majeti, R., et al. (2019) · Diabetes · doi:10.2337/db18-0638 · Cited by 338
Self-citationFoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis
Sanchez, A. M. J., Candau, R. B., & Bernardi, H. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1513-z · Cited by 335
Kodama, S., Koike, C., Negishi, M., & Yamamoto, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7931-7940.2004 · Cited by 334
Selenoproteins: Antioxidant selenoenzymes and beyond
Steinbrenner, H., Speckmann, B., & Klotz, L.-O. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.06.024 · Cited by 327
FURUYAMA, T., KITAYAMA, K., YAMASHITA, H., & MORI, N. (2003) · Biochemical Journal · doi:10.1042/bj20030022 · Cited by 326
Molecular mechanisms of insulin resistance
Schinner, S., Scherbaum, W. A., Bornstein, S. R., & Barthel, A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01566.x · Cited by 319
Wang, R.-H., Kim, H.-S., Xiao, C., Xu, X., Gavrilova, O., & Deng, C.-X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46243 · Cited by 314
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
Altomonte, J., Lin, C., Harbaran, S., Richter, A. M., Xu, J., Meseck, M. L., & Dong, H. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19992 · Cited by 309
Phosphorylation of Serine 256 Suppresses Transactivation by FKHR (FOXO1) by Multiple Mechanisms
Zhang, X., Gan, L., Pan, H., Guo, S., He, X., Olson, S. T., Mesecar, A., Adam, S., & Unterman, T. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208063200 · Cited by 294
Self-citationThe Role of Estrogen in Insulin Resistance
De Paoli, M., Zakharia, A., & Werstuck, G. H. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.05.011 · Cited by 290
Molecular mechanisms of insulin resistance in type 2 diabetes mellitus
Saini, V. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i3.68 · Cited by 288
Tanoue, T., Maeda, R., Adachi, M., & Nishida, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.466 · Cited by 285
Burgess, S. C., He, T., Yan, Z., Lindner, J., Sherry, A. D., Malloy, C. R., Browning, J. D., & Magnuson, M. A. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.004 · Cited by 276
Regulation of PGC-1 Promoter Activity by Protein Kinase B and the Forkhead Transcription Factor FKHR
Daitoku, H., Yamagata, K., Matsuzaki, H., Hatta, M., & Fukamizu, A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.642 · Cited by 262
C1q/TNF-related Protein-3 (CTRP3), a Novel Adipokine That Regulates Hepatic Glucose Output
Peterson, J. M., Wei, Z., & Wong, G. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180695 · Cited by 257
Vascular Endothelial Growth Factor Activates PI3K/Akt/Forkhead Signaling in Endothelial Cells
Abid, M. R., Guo, S., Minami, T., Spokes, K. C., Ueki, K., Skurk, C., Walsh, K., & Aird, W. C. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000110502.10593.06 · Cited by 248
Self-citationConvergence of Peroxisome Proliferator-activated Receptor γ and Foxo1 Signaling Pathways
Dowell, P., Otto, T. C., Adi, S., & Lane, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309069200 · Cited by 233
O-Sullivan, I., Zhang, W., Wasserman, D. H., Liew, C. W., Liu, J., Paik, J., DePinho, R. A., Stolz, D. B., Kahn, C. R., Schwartz, M. W., et al. (2015) · Nature Communications · doi:10.1038/ncomms8079 · Cited by 228
Self-citationInhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice
Altomonte, J., Richter, A., Harbaran, S., Suriawinata, J., Nakae, J., Thung, S. N., Meseck, M., Accili, D., & Dong, H. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00156.2003 · Cited by 227
“In response to insulin, Foxo1 undergoes phosphatidylinositol (PI) 3-kinase-dependent phosphorylation and is excluded from the nucleus, resulting in inhibition of Foxo1-dependent transcription (2, 5, 6, 13, 22, 27).”
Chakravarty, K., Cassuto, H., Reshef, L., & Hanson, R. W. (2005) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230590935479 · Cited by 219
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner
Pajvani, U. B., Shawber, C. J., Samuel, V. T., Birkenfeld, A. L., Shulman, G. I., Kitajewski, J., & Accili, D. (2011) · Nature Medicine · doi:10.1038/nm.2378 · Cited by 193
Jitrapakdee, S. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.001 · Cited by 195
Hepatic Suppression of Foxo1 and Foxo3 Causes Hypoglycemia and Hyperlipidemia in Mice
Zhang, K., Li, L., Qi, Y., Zhu, X., Gan, B., DePinho, R. A., Averitt, T., & Guo, S. (2012) · Endocrinology · doi:10.1210/en.2011-1527 · Cited by 179
Self-citationRegulation of metabolic transcriptional co‐activators and transcription factors with acute exercise
Russell, A. P., Hesselink, M. K. C., Lo, S. K., & Schrauwen, P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3168fje · Cited by 177
Samuel, V. T., Beddow, S. A., Iwasaki, T., Zhang, X.-M., Chu, X., Still, C. D., Gerhard, G. S., & Shulman, G. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812547106 · Cited by 176
Steinbrenner, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.016 · Cited by 172
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Valenti, L., Bugianesi, E., Pajvani, U., & Targher, G. (2016) · Liver International · doi:10.1111/liv.13185 · Cited by 171
O-GlcNAc modification, insulin signaling and diabetic complications
Issad, T., Masson, E., & Pagesy, P. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.001 · Cited by 170
Ono, H., Shimano, H., Katagiri, H., Yahagi, N., Sakoda, H., Onishi, Y., Anai, M., Ogihara, T., Fujishiro, M., Viana, A. Y. I., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2905 · Cited by 169
Narasimhan, A., Chinnaiyan, M., & Karundevi, B. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0002 · Cited by 164
Kwon, H.-S., Huang, B., Unterman, T. G., & Harris, R. A. (2004) · Diabetes · doi:10.2337/diabetes.53.4.899 · Cited by 158
Self-citationHuman aquaporin adipose (AQPap) gene. Genomic structure, promoter analysis and functional mutation
Kondo, H., Shimomura, I., Kishida, K., Kuriyama, H., Makino, Y., Nishizawa, H., Matsuda, M., Maeda, N., Nagaretani, H., Kihara, S., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02821.x · Cited by 172
MicroRNA 33 Regulates Glucose Metabolism
Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00016-13 · Cited by 154
Guo, S., Copps, K. D., Dong, X., Park, S., Cheng, Z., Pocai, A., Rossetti, L., Sajan, M., Farese, R. V., & White, M. F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00138-09 · Cited by 152
Self-citationVander Kooi, B. T., Onuma, H., Oeser, J. K., Svitek, C. A., Allen, S. R., Vander Kooi, C. W., Chazin, W. J., & O’Brien, R. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0497 · Cited by 153
Molecular Mechanisms of Insulin Resistance in IRS-2-Deficient Hepatocytes
Valverde, A. M., Burks, D. J., Fabregat, I., Fisher, T. L., Carretero, J., White, M. F., & Benito, M. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2239 · Cited by 144
Role of FoxO transcription factors in aging and age-related metabolic and neurodegenerative diseases
Du, S., & Zheng, H. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00700-7 · Cited by 166
Lansard, M., Panserat, S., Plagnes‐Juan, E., Seiliez, I., & Cassy, S. (2010) · Amino Acids · doi:10.1007/s00726-010-0533-3 · Cited by 154
In control of biology: of mice, men and Foxes
Wijchers, P. J. E. C., Burbach, J. P. H., & Smidt, M. P. (2006) · Biochemical Journal · doi:10.1042/bj20060387 · Cited by 139
Docking interactions in the mitogen-activated protein kinase cascades
Tanoue, T., & Nishida, E. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00188-2 · Cited by 134
FoxO1 integrates insulin signaling to VLDL production.
Kamagate, A., & Dong, H. H. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6882 · Cited by 127
Koh, Y.-K., Lee, M.-Y., Kim, J. W., Kim, M., Moon, J., Lee, Y.-J., Ahn, Y., & Kim, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804007200 · Cited by 130
Kishida, K., Shimomura, I., Kondo, H., Kuriyama, H., Makino, Y., Nishizawa, H., Maeda, N., Matsuda, M., Ouchi, N., Kihara, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106040200 · Cited by 124
Hirota, K., Sakamaki, J.-I., Ishida, J., Shimamoto, Y., Nishihara, S., Kodama, N., Ohta, K., Yamamoto, M., Tanimoto, K., & Fukamizu, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806179200 · Cited by 123
Lansard, M., Panserat, S., Plagnes‐Juan, E., Dias, K., Seiliez, I., & Cassy, S. (2010) · Journal of Nutrition · doi:10.3945/jn.110.124511 · Cited by 131
A Role of the Bile Salt Receptor FXR in Atherosclerosis
Hageman, J., Herrema, H., Groen, A. K., & Kuipers, F. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197897 · Cited by 119
Abid, M. R., Yano, K., Guo, S., Patel, V. I., Shrikhande, G., Spokes, K. C., Ferran, C., & Aird, W. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502149200 · Cited by 116
Self-citationYeagley, D., Guo, S., Unterman, T. G., & Quinn, P. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101215200 · Cited by 125
Self-citationFOXO transcription factors at the interface of metabolism and cancer
Link, W., & Fernández-Marcos, P. J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30840 · Cited by 123
Plagnes‐Juan, E., Lansard, M., Seiliez, I., Médale, F., Corraze, G. R., Kaushik, S., Panserat, S., & Cassy, S. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.018374 · Cited by 132
Mounier, C., & Posner, B. I. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-152 · Cited by 114
Atypical protein kinase C in insulin action and insulin resistance
Farese, R. V., Sajan, M. P., & Standaert, M. L. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330350 · Cited by 114
Roth, U., Curth, K., Unterman, T. G., & Kietzmann, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308391200 · Cited by 112
Self-citationKuo, M.-S., Zilberfarb, V., Gangneux, N., Christeff, N., & Issad, T. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.010 · Cited by 131
Targeting xenobiotic receptors PXR and CAR in human diseases
Banerjee, M., Robbins, D. F., & Chen, T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.011 · Cited by 120
Monsalve, M., & Olmos, Y. (2011) · Current Drug Targets · doi:10.2174/138945011796150307 · Cited by 124
van der Heide, L. P., Jacobs, F. M. J., Burbach, J. P. H., Hoekman, M. F. M., & Smidt, M. P. (2005) · Biochemical Journal · doi:10.1042/bj20050525 · Cited by 110
Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy
Kandula, V., Kosuru, R., Li, H., Yan, D., Zhu, Q., Lian, Q., Ge, R., Xia, Z., & Irwin, M. G. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0361-1 · Cited by 122
Deng, L., Shoji, I., Ogawa, W., Kaneda, S., Soga, T., Jiang, D., Ide, Y.-H., & Hotta, H. (2011) · Journal of Virology · doi:10.1128/jvi.00146-11 · Cited by 113
Barthel, A., Schmoll, D., Krüger, K.-D., Bahrenberg, G., Walther, R., Roth, R. A., & Joost, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5261 · Cited by 105
Self-citationHe, J., Chen, L.-X., & Li, H. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.02.033 · Cited by 108
Gebhardt, R., & Hovhannisyan, A. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22041 · Cited by 102
Hirota, K., Daitoku, H., Matsuzaki, H., Araya, N., Yamagata, K., Asada, S., Sugaya, T., & Fukamizu, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200553200 · Cited by 109
Wu, Z., Jiao, P., Huang, X., Feng, B., Feng, Y., Yang, S., Hwang, P., Du, J., Nie, Y., Xiao, G., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43250 · Cited by 102
Characterization of a Protein Kinase B Inhibitor In Vitro and in Insulin-Treated Liver Cells
Logie, L., Ruiz‐Alcaraz, A. J., Keane, M. P., Woods, Y. L., Bain, J., Márquez, R., Alessi, D. R., & Sutherland, C. D. (2007) · Diabetes · doi:10.2337/db07-0343 · Cited by 120
Self-citationCooper, M. P., Qu, L., Rohas, L. M., Lin, J., Yang, W., Erdjument-Bromage, H., Tempst, P., & Spiegelman, B. M. (2006) · Genes & Development · doi:10.1101/gad.1483906 · Cited by 100
Novel Mechanism of Foxo1 Phosphorylation in Glucagon Signaling in Control of Glucose Homeostasis
Wu, Y., Pan, Q., Yan, H., Zhang, K., Guo, X., Xu, Z., Yang, W., Qi, Y., Guo, C., Hornsby, C., et al. (2018) · Diabetes · doi:10.2337/db18-0674 · Cited by 103
Self-citationTGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis
Yadav, H., Devalaraja, S., Chung, S. T., & Rane, S. G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764910 · Cited by 108
FOXO1: A Potential Target for Human Diseases
Lu, H., & Huang, H. (2011) · Current Drug Targets · doi:10.2174/138945011796150280 · Cited by 100
The Fox Genes in the Liver: From Organogenesis to Functional Integration
Lay, J. E. L., & Kaestner, K. H. (2010) · Physiological Reviews · doi:10.1152/physrev.00018.2009 · Cited by 104
FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner
McLoughlin, T. J., Smith, S. M., DeLong, A. D., Wang, H., Unterman, T. G., & Esser, K. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00502.2008 · Cited by 90
Self-citation
Metadata
- Authors
- Schmoll, D., Walker, K. S., Alessi, D. R., Grempler, R., Burchell, A., Guo, S., Walther, R., & Unterman, T. G.
- Affiliations
- Universität Greifswald (DE)
- University of Dundee (GB)
- University of Illinois Chicago (US)
- Corresponding author
- Schmoll, Dieter
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 275
- Issue
- 46
- Pages
- 36324-36333
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2090759987
- Cited by
- 349
- References
- 37
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 4 · 2022: 8 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 13 · 2017: 12 · 2016: 11 · 2015: 15 · 2014: 14 · 2013: 11 · 2012: 12
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7274 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 41430)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- glucose-6-phosphatase, gene expression regulation, insulin signaling, hepatic glucose production, H4IIE cells, transcriptional regulation
- MeSH terms
- Forkhead Box Protein O1, Cyclic AMP, Animals, Binding Sites, Dexamethasone, DNA, DNA-Binding Proteins, Glucose-6-Phosphatase, Isoenzymes, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Nuclear Proteins, Promoter Regions, Genetic, Proto-Oncogene Proteins, RNA, Messenger, Transcription Factors, Transfection, Tumor Cells, Cultured, Gene Expression Regulation, Enzymologic, Protein Serine-Threonine Kinases, Response Elements, Proto-Oncogene Proteins c-akt, Rats, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.